What is the ticker symbol for Aerpio Pharmaceuticals?

Aerpio Pharmaceuticals trades under the ticker ARPO on NASDAQ.

What sector does Aerpio Pharmaceuticals operate in?

Aerpio Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ARPO in a portfolio?

PortView shows ARPO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Aerpio Pharmaceuticals (ARPO) Stock Analysis

NASDAQHealthcareBiotechnology

$2.20-0.90%

52-week range$2.20

$2.16$49.80

What Aerpio Pharmaceuticals does

Aerpio Pharmaceuticals Inc., a biopharmaceutical enterprise headquartered in Blue Ash, Ohio, currently employs 27 full-time staff. The company's core mission revolves around the research and development of therapeutic solutions for ocular diseases. Its product pipeline is spearheaded by AKB-9778, with two additional programs, AKB-4924 and ARP-1536, also under development. AKB-9778 is a small molecule designed to activate the Tie-2 pathway, intended for the treatment of diabetic retinopathy (DR). AKB-4924, another candidate, functions as a selective stabilizer of hypoxia-inducible factor-1 alpha (HIF-1alpha) and is being investigated for its potential in treating inflammatory bowel disease (IBD). ARP-1536 is a humanized monoclonal antibody that targets the same pathway as AKB-9778. It operates by attaching to the extracellular domain of vascular endothelial protein tyrosine phosphatase (VE-PTP), thereby inhibiting its interaction with Tie-2. As of April 14, 2017, Aerpio had successfully concluded a Phase II clinical trial for AKB-9778, which involved 144 patients with diabetic macular edema. By the same date, a Phase Ia clinical trial for AKB-4924 in healthy volunteers had also been completed.

Key metrics

Market cap

$53.67M

P/E (TTM)

0.00

EPS (TTM)

$0.00

Beta

1.65

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$31.53

200-day avg

$25.92

52-week high

$49.80

52-week low

$2.16

ETFs linked to ARPO

Broad-market and Healthcare sector ETFs an investor holding Aerpio Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ARPO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ARPO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Aerpio Pharmaceuticals?: Aerpio Pharmaceuticals trades under the ticker ARPO on NASDAQ.
Which exchange is ARPO listed on?: ARPO is listed on NASDAQ.
What sector does Aerpio Pharmaceuticals operate in?: Aerpio Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ARPO in a portfolio?: PortView shows ARPO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.